Does low entry of cystic duct predispose to stones in the common bile duct? P C Bornman, R E Kottler, J Terbianche, A N Kingsnorth, J E J Krige, I N Marks
In patients undergoing endoscopic papillotomy for stones in the bile duct the cystic duct often seems to enter the bile duct low down from the left (see fig (a) ). To substantiate this impression the site of entry of the cystic duct in patients with stones in the bile duct was compared with that in patients with stones in the gall bladder and that in a group of control patients.
Patients, methods, and results
The position of the entry of the cystic duct into the common hepatic duct was studied in a consecutive series of 50 patients with stones in the bile duct by reviewing endoscopic retrograde cholangiograms. Sixteen patients had a cholecystectomy; associated stones were seen in 22 of the 34 with intact gall bladders. These results were compared with the routine operative cholangiograms of 50 patients with stones in the gall bladder but no evidence of stones in the bile duct and with those of 50 control patients with abdominal pain and normal results from endoscopic retrograde cholangiopancreatography.
The figure (b) shows the segments of the bile duct measured. To overcome discrepancies due to the type of cholangiogram distances from the ampulla to the 2 3 (a) Left sided entry of cystic duct at level of ampulla of Vater. (b) Measurements of segments of bile duct: I ampulla ofVater to entry ofcystic duct, 2 contiguous segment ofcystic duct and common hepatic duct, and 3 total length of bile duct. A=Ampullary diverticulum entry of the cystic duct (segment 1) and the contiguous segment of the cystic duct (segment 2) were expressed as ratios of the total length of the bile duct (segment 3). Periampullary diverticula were also documented. The unpaired Student's, X2I and
Fisher's exact tests were used for statistical analyses when appropriate. The mean age of the group with stones in the bile duct was 65 (SD 16), which was higher than that of the group with stones in the gall bladder (52 (13 2)) and that of control patients (47 (15 9)) (p<0001 in both cases). The group with stones in the bile duct contained more men than the group with stones in the gall bladder (n=24 and 10, respectively; p<0001).
The ratio of segments 1 to 3 was significantly lower in the group with stones in the bile duct, being 0-28 (0 20) compared with 0-55 (0-16) in the group with stones in the gall bladder and 0 54 (0 19) in the control group (p<0 001 in both cases). Conversely, the ratio of segments 2 to 3 was significantly higher in the group with stones in the bile duct, being 0 43 (0-15) compared with 0-21 (0 14) in the group with stones in the gall bladder and 0-21 (0 15) in the control group (p<0-001). Low entry of the cystic duct was defined as less than 3 5 cm from the ampulla and was more common in the group with stones in the bile duct (n=28) than in the group with stones in the gall bladder or in the control group (n=12 and 5, respectively; p<0005). Ampullary diverticula were also significantly more common among those with stones in the bile duct (17 out of 50) than among control patients (three out of 50) (p<0001), but no clear association was found between ampullary diverticula and low entry of the cystic duct. The combination ofa left sided and low entry of the cystic duct into the bile duct was more common in patients with stones in the bile duct (17 out of 50) than in those with stones in the gall bladder (three out of 50) (p<0-001) or those in the control group (four out of 50) (p<0003). This combination was noted in all nine patients aged less than 30 and in all five black patients (mean age 42, range 22-52) with stones in the bile duct in our total experience with bile duct stones.
Comment
Our study shows that stones in the bile duct are commonly associated with a low and often left sided entry of the cystic duct into the bile duct. The pathogenetic relevance of this is reinforced by the invariable finding of this anatomical variant in young and in black patients, in whom stones in the bile duct are otherwise rare. Although the mechanism for the formation of such stones is uncertain, stasis with colonisation and the formation of calcium bilirubinate stones is probable.'2 Alternatively, low entry of the cystic duct may lead to increased retrograde pressure BMJ VOLUME 297with gradual dilatation of the cystic duct and migration of stones from the gall bladder.3
There are several clinical implications. The long contiguous course of the cystic duct and common hepatic duct could explain why surgeons sometimes inadvertently leave a long remnant of cystic duct, which is reputedly a cause of the postcholecystectomy syndrome.4 Furthermore, the migration of stones from the gall bladder into the contiguous segment may explain transient episodes of jaundice and, with more severe impaction of stones, cause persistent obstructive jaundice, the so called Mirizzi syndrome.
We 
Patients, methods, and results
We designed a questionnaire to assess inpatients' knowledge of their prescribed glyceryl trinitrate. Questions were included about how glyceryl trinitrate works, dosage, how to take and store it, side effects, and what to do should side effects occur. Fifty patients, 28 men (mean age 62 (SD 11-6) years) and 22 women (mean age 67 4 (12) years), were studied. The mean time of treatment with sublingual glyceryl trinitrate was 5 5 years (range one week to 12 years).
Only one of us (EAK) collected data from the questionnaire. Correct answers scored one point and incorrect or "don't know" responses none. Two questions required multiple answers. A maximum score of six points was awarded for knowing how to take a tablet correctly, one point being given for each of tipping some tablets into the bottle cap, selecting one; sitting down or standing still for a moment; placing one tablet under the tongue; not eating, drinking, or smoking while taking the drug; and replacing the cap of the bottle tightly. A maximum of four points was awarded for side effects, one for each of headache, flushing, dizziness, and burning sensation in the mouth. The correct answer for the drug's dosage was taking a maximum of three tablets in 15 minutes-the second tablet five minutes after the first and the third five minutes after the second-and thereafter seeking medical help if this regimen was ineffective.
Only 15 patients remembered receiving advice about their tablets. Forty seven patients knew the indication for their use. Most called their tablets GTN, and 13 also knew them as either TNT or trinitrin. Six patients understood glyceryl trinitrate's mode of action. Six patients understood the word "sublingual," and 25 knew that these tablets could be used prophylactically. The patients' knowledge of the dosing, storage, and side effects was poor (table) .
Comment
Patients showed a depressing lack of knowledge of their drug treatment, and many did not know how to take sublingual glyceryl trinitrate tablets correctly. 
